IHE

Innovative ETFs Channel

Legal Troubles Beset Pharmaceutical Sector ETFs

By Max ChenMay 14, 2019

Innovative ETFs Channel

Pharmaceutical ETFs Catch Healthcare Contagion

By Max ChenApril 18, 2019

Equity ETF Channel

Tom Lydon on CNBC: Can Health Care Cure Itself?

By Ben HernandezApril 15, 2019

Tactical Allocation Channel

4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat

By Ben HernandezApril 9, 2019

Equity ETFs

Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder

By Max ChenDecember 14, 2018

Equity ETFs

ETF Plays for a Divided Midterm Elections

By Max ChenOctober 22, 2018

Equity ETFs

Pharmaceutical ETFs Could Maintain Their Momentum

By Max ChenSeptember 6, 2018

Equity ETFs

July Could Be a Volatile Month for Pharma ETFs

By Max ChenJuly 3, 2018

Equity ETFs

Get Lucky With 10 Saint Patrick’s Day ETFs

By Amiya MorettaMarch 16, 2018

Equity ETFs

Getting Defensive With Healthcare ETFs as Congress Moves to Replace Obamacare

By Tom LydonMay 8, 2017

Equity ETFs

Drug Makers, Pharma ETFs Face a Tough Earnings Season

By Max ChenApril 24, 2017

Equity ETFs

Good News for Healthcare ETFs After Dodging Obamacare Repeal

By Brenton GarenApril 7, 2017

Equity ETFs

Finding Pharmaceuticals ETFs With Rebound Potential

By Tom LydonMay 4, 2016

Equity ETFs

17 Healthcare ETFs Investors Should Check Up On

By Tom LydonApril 28, 2016

Featured

Major Pharma Merger Boosts ETFs

By Tom LydonOctober 29, 2015

Featured

ETFs to Capitalize Off Obamacare Fueled Growth

By Tom LydonJuly 29, 2015

Featured

M&A Activity Will Support Pharma ETFs Through Rising Rate Environment

By Tom LydonJuly 9, 2015

Featured

Healthcare ETFs: Specialized Drugs in Greater Demand

By Tom LydonJuly 7, 2015